Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Shotan

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
The American Journal of Cardiology|June 15, 1996
Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study GroupM Jonas, H Reicher-Reiss, V Boyko, et al.
European Heart Journal|January 1, 1997
Low total cholesterol is associated with high total mortality in patients with coronary heart disease. The Bezafibrate Infarction Prevention (BIP) Study GroupS Behar, E Graff, H Reicher-Reiss, et al.
The American Journal of Cardiology|June 30, 1998
Effect of beta-blocker therapy in patients with coronary artery disease in New York Heart Association classes II and III. The Bezafibrate Infarction Prevention (BIP) Study GroupM Haim, A Shotan, V Boyko, et al.
Pharmacotherapy|August 6, 1998
Pharmacokinetic and pharmacodynamic evaluation of atenolol during and after pregnancyA K Hurst, A Shotan, K Hoffman, et al.
American Heart Journal|November 1, 1986
Amiodarone as a cause of electrocardiographic changes simulating myocardial ischemia or subendocardial infarctionZ Rotstein, A Schneeweiss, A Shotan, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|August 25, 2000
Abciximab in carotid stenting for postsurgical carotid restenosis: intermediate resultsJ Schneiderman, B Morag, A Gerniak, et al.
The American Journal of Cardiology|January 5, 1999
Prognostic significance of cerebrovascular disease in 11,526 chronic coronary artery disease patients. Bezafibrate Infarction Prevention (BIP) Study GroupH Reicher-Reiss, M Jonas, D Tanne, et al.
Circulation|May 25, 1999
Double-blind, placebo-controlled study to evaluate the effect of organic nitrates in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitionU Elkayam, J V Johnson, A Shotan, et al.
Circulation|November 1, 1991
Randomized study to evaluate the relation between oral isosorbide dinitrate dosing interval and the development of early tolerance to its effect on left ventricular filling pressure in patients with chronic heart failureU Elkayam, A Roth, A Mehra, et al.
Circulation|November 15, 2000
Sex differences in management and outcome after acute myocardial infarction in the 1990s: A prospective observational community-based study. Israeli Thrombolytic Survey GroupS Gottlieb, D Harpaz, A Shotan, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
The American Journal of Cardiology|June 15, 1996
Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study GroupM Jonas, H Reicher-Reiss, V Boyko, et al.
European Heart Journal|January 1, 1997
Low total cholesterol is associated with high total mortality in patients with coronary heart disease. The Bezafibrate Infarction Prevention (BIP) Study GroupS Behar, E Graff, H Reicher-Reiss, et al.
The American Journal of Cardiology|June 30, 1998
Effect of beta-blocker therapy in patients with coronary artery disease in New York Heart Association classes II and III. The Bezafibrate Infarction Prevention (BIP) Study GroupM Haim, A Shotan, V Boyko, et al.
Pharmacotherapy|August 6, 1998
Pharmacokinetic and pharmacodynamic evaluation of atenolol during and after pregnancyA K Hurst, A Shotan, K Hoffman, et al.
American Heart Journal|November 1, 1986
Amiodarone as a cause of electrocardiographic changes simulating myocardial ischemia or subendocardial infarctionZ Rotstein, A Schneeweiss, A Shotan, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|August 25, 2000
Abciximab in carotid stenting for postsurgical carotid restenosis: intermediate resultsJ Schneiderman, B Morag, A Gerniak, et al.
The American Journal of Cardiology|January 5, 1999
Prognostic significance of cerebrovascular disease in 11,526 chronic coronary artery disease patients. Bezafibrate Infarction Prevention (BIP) Study GroupH Reicher-Reiss, M Jonas, D Tanne, et al.
Circulation|May 25, 1999
Double-blind, placebo-controlled study to evaluate the effect of organic nitrates in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitionU Elkayam, J V Johnson, A Shotan, et al.
Circulation|November 1, 1991
Randomized study to evaluate the relation between oral isosorbide dinitrate dosing interval and the development of early tolerance to its effect on left ventricular filling pressure in patients with chronic heart failureU Elkayam, A Roth, A Mehra, et al.
Circulation|November 15, 2000
Sex differences in management and outcome after acute myocardial infarction in the 1990s: A prospective observational community-based study. Israeli Thrombolytic Survey GroupS Gottlieb, D Harpaz, A Shotan, et al.
Pageof 4